Malignant melanoma in organ allograft recipients

Transplantation

Volumn 61, Issue 2, 1996, Pages 274-278

  Penn, Israel ^a  

^a UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ALLOGRAFT; ARTICLE; BRAIN METASTASIS; CANCER RISK; CHILD; CLINICAL ARTICLE; FEMALE; GRAFT REJECTION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LYMPH NODE METASTASIS; MALE; MELANOMA; PRIORITY JOURNAL; RECIPIENT; SKIN CANCER; SUNLIGHT;

HUMANS; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MELANOMA; ORGAN TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 0030040747     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199601270-00019     Document Type: Article

References (36)

1. Penn I. Immunosuppression and skin cancer. Clin Plast Surg 1980; 7: 361.
2. Penn I. Posttransplant kidney cancers and skin cancers (including Kaposi's sarcoma), In: Schmähl D, Penn I, eds. Cancer in organ transplant recipients. Berlin: Springer, 1991: 46.
3. Penn I. Malignancy. Surg Clin North Am 1994; 74: 1247.
4. Autier P. Epidemiology of melanoma. In: Lejeune FJ, Chaudhuri PK, Das Gupta TK, eds. Malignant melanoma: medical and surgical management. New York: McGraw-Hill, 1994: 1.
5. Penn I. Donor transmitted disease: cancer. Transplant Proc 1991; 23: 2629.
6. Penn I. Transmission of cancer from donor organs. Nefrologia (in press).
7. Wilson LJ, Horvat RT, Tilzer L, Meis AM, Montag L, Huntrakoon M. Identification of donor melanoma in a renal transplant recipient. Diagn Mol Pathol 1992; 1: 266.
8. Jeremy D, Farnsworth RH, Robertson MR, Annetts DL, Murnaghan GF. Transplantation of malignant melanoma with cadaver kidney. Transplantation 1972; 13: 619.
9. Peters MS, Stuard ID. Metastatic malignant melanoma transplanted via a renal homograft: a case report. Cancer 1978; 41: 2426.
10. Fairman RM, Grossman RA, Barker CF, Perloff LJ. Inadvertent transplantation of a melanoma. Transplantation 1980; 30: 328.
11. Younis FM, Fernando ON, Sweny P, Baillod R, Moorhead, J. Malignant melanoma in patient with renal transplant. Lancet 1980; 2: 1141.
12. Merkle T, Landthaler M, Eckert F, Braun-Falco O. Acral verrucous malignant melanoma in an immunosuppressed patient after kidney transplantation. J Am Acad Dermatol 1991; 24: 505.
13. Penn I. Malignancy in transplanted organs (editorial). Transplant Int 1993; 6: 1.
14. Penn I. Effects of immunosuppression on pre-existing cancers. Transplantation 1993; 55: 742.
15. Farzad Z, McBride WH, Cochran AJ. Immunology of melanoma. In: Lejeune FJ, Chaudhuri PK, Das Gupta TK, eds. Malignant melanoma: medical and surgical management. New York: McGraw-Hill, 1994: 27.
16. Greene MH, Young TI, Clark WH Jr. Malignant melanoma in renal transplant recipients. Lancet 1981; 1: 1196.
17. Hoover RN. Effects of drugs: immunosuppression. In Hiatt HH, Watson JD, Winsten JA, eds. Origins of human cancer. New York: Cold Spring Harbor Laboratory 1977: 369.
18. Kinlen LJ, Sheil AG, Peto J, Doll R. Collaborative United Kingdom - Australasian study of cancer in patients treated with immunosuppressive drugs. Br Med J 1979; 2: 1461.
19. Sheil AGR. Cancer after transplantation. World J Surg 1986; 10: 389.
20. Char DH. Primary ocular melanomas. In: Lejeune FJ, Chaudhuri PK, Das Gupta TK, eds. Malignant melanoma: medical and surgical management. New York: McGraw-Hill, 1994: 343.
21. Cochran AJ, Binder S, Remotti F. The role of microscopic evaluation in the management of cutaneous melanoma. In: Nathanson L, ed. Current research and clinical management of melanoma. Boston: Kluwer, 1993; 69.
22. Boddie AW Jr, Smith, JL Jr, McBride CM. Malignant melanoma in children and young adults: effects of diagnostic criteria on staging and end results. South Med J 1978; 71: 1074.
23. Ceballos PI, Ruiz-Maldonado R, Mihm MC Jr. Melanoma in children. N Engl J Med 1995; 332: 656.
24. Lishner M, Patterson B, Kandel R, et al. Cutaneous and mucosal neoplasms in bone marrow transplant recipients. Cancer 1990; 65: 473.
25. Koh HK, Sinks TH, Geller AC, Miller DR, Lew, RA. Etiology of melanoma. In Nathanson L, ed. Current research and clinical management of melanoma. Boston: Kluwer, 1993: 1.
26. Barker JN, MacDonald DM. Eruptive dysplastic nevi following renal transplantation. Clin Exp Dermatol 1988; 13: 123.
27. McGregor JM, Barker JN, MacDonald DM. The development of excess numbers of melanocytic naevi in an immunosuppressed identical twin. Clin Exp Dermatol 1991; 16: 131.
28. Greene MH. The prevention of cutaneous malignant melanoma: high-risk groups, chemoprevention, education, and screening. In Nathanson L, ed. Current research and clinical management of melanoma. Boston: Kluwer, 1993: 103.
29. Green AC, O'Rourke MGE. Cutaneous malignant melanoma in association with other skin cancer. J Natl Cancer Inst 1985; 74: 977.
30. Holman CDJ, Armstrong BK. Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. J Natl Cancer Inst 1984; 73: 75.
31. Hemmens VJ, Moore DE. Photochemical sensitization by azathioprine and its metabolites: II. azathioprine and nitroimidazole metabolites. Photochem Photobiol 1986; 43: 257.
32. Taylor AEM, Shuster S. Skin cancer after renal transplantation: the causal role of azathioprine. Arch Derm Venereol (Stockh) 1992; 72: 115.
33. Lennard L, Thomas S, Harrington CI, Maddocks JL. Skin cancer in renal transplant recipients is associated with increased concentrations of 6-thioguanine nucleotide in red blood cells. Br J Dermatol 1985; 113: 723.
34. Spees EK Jr, Kramer KK, Light JA, Oakes DD, Zimmerman LE. Reaction of ocular malignant melanoma after renal transplantation. Transplantation 1980; 29: 421.
35. Balch CM, Murad TM, Soong SJ, Ingalls AL, Halpern NB, Maddox WA. A multifactorial analysis of melanoma: prognostic histopathological features comparing Clark's and Breslow staging methods. Ann Surg 1978; 188: 732.
36. Cuchural GJ Jr, Levey AS, Parker SG. Kidney failure or cancer: should immunosuppression be continued in a transplant patient with malignant melanoma? Med Decis Making 1984; 4: 82.